(L-R) Mr Thierry Cournez, director, global sales development, Merck Millipore, Mr Sanjit S Lamba, MD, Eisai Knowledge Centre, Mr Dhilip Kumar, president, AIDCOC, Dr John Purves, life science consultant, Dr Jagshetty, Drug Controller of Karnataka, Mr S M Mudda, executive director, technical and operations, Microlabs, Dr Rustom Mody, senior VP (R&D), Lupin Ltd, Mr H S Dayananda, head, Biopharm Process Solutions, Merck Millipore (India)
Experts from Drug Control Department from government of India, pharmaceutical and biopharmaceutical industry came together to discuss and deliberate on various current key areas of focus in the industry.
The topic discussion ranged from challenges and developments in aseptic processing, manufacture of biosimilars, to current regulatory and manufacturing trends and advancements in vaccine manufacturing technologies. The event witnessed about thirty speakers and panelists from India and abroad, along with senior officials from the regulatory agencies.
Dr B R Jagashetty, Drugs Controller of Karnataka and guest of honor for the event, in his address said that Drug Control Department of Karnataka (DCDK) has taken a step ahead in investing and upgrading the drug control testing labs in order to make them equivalent to, or better than, any private testing labs.
Lectures were also delivered by fourteen eminent professionals and subject matter experts (SMEs) from India and abroad on topics related to current trends, processes and regulations for the pharmaceutical and biotech Industry.